世界の代謝型グルタミン酸受容体(MRG)市場2020:製造業者別、地域別、種類・用途別

【英語タイトル】Global Metabotropic Glutamate Receptor (MRG) Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20MY10068)・商品コード:GIR20MY10068
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年5月(※2024年版があります。お問い合わせください)
・ページ数:109
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、代謝型グルタミン酸受容体(MRG)の世界市場を広く調査・分析し、今後の市場展望をまとめております。代謝型グルタミン酸受容体(MRG)の種類別市場規模(mGluR2、mGluR4、mGluR5)、用途別市場規模(髄膜炎、敗血症、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Addex Therapeutics (Switzerland)、Prexton Therapeutics (Switzerland)、Domain Therapeutics (France)、Medgenics (USA)、Taisho Pharmaceutical Holding (Japan)
・地域別グローバル市場分析 2015年-2020年
・代謝型グルタミン酸受容体(MRG)の北米市場(アメリカ、カナダ、メキシコ)
・代謝型グルタミン酸受容体(MRG)のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・代謝型グルタミン酸受容体(MRG)のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・代謝型グルタミン酸受容体(MRG)の南米市場(ブラジル、アルゼンチン)
・代謝型グルタミン酸受容体(MRG)の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:mGluR2、mGluR4、mGluR5
・用途別分析:髄膜炎、敗血症、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The global Metabotropic Glutamate Receptor (MRG) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Metabotropic Glutamate Receptor (MRG) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Metabotropic Glutamate Receptor (MRG) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Metabotropic Glutamate Receptor (MRG) market has been segmented into
mGluR2
mGluR4
mGluR5

By Application, Metabotropic Glutamate Receptor (MRG) has been segmented into:
Meningitis
Septicemia
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Metabotropic Glutamate Receptor (MRG) market presented in the report. This section sheds light on the sales growth of different regional and country-level Metabotropic Glutamate Receptor (MRG) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Metabotropic Glutamate Receptor (MRG) market.

The report offers in-depth assessment of the growth and other aspects of the Metabotropic Glutamate Receptor (MRG) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Metabotropic Glutamate Receptor (MRG) Market Share Analysis
Metabotropic Glutamate Receptor (MRG) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Metabotropic Glutamate Receptor (MRG) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Metabotropic Glutamate Receptor (MRG) sales, revenue and market share for each player covered in this report.

The major players covered in Metabotropic Glutamate Receptor (MRG) are:
Addex Therapeutics (Switzerland)
Prexton Therapeutics (Switzerland)
Domain Therapeutics (France)
Medgenics (USA)
Taisho Pharmaceutical Holding (Japan)

Among other players domestic and global, Metabotropic Glutamate Receptor (MRG) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Metabotropic Glutamate Receptor (MRG) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Metabotropic Glutamate Receptor (MRG), with price, sales, revenue and global market share of Metabotropic Glutamate Receptor (MRG) in 2018 and 2019.
Chapter 3, the Metabotropic Glutamate Receptor (MRG) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Metabotropic Glutamate Receptor (MRG) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Metabotropic Glutamate Receptor (MRG) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Metabotropic Glutamate Receptor (MRG) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Metabotropic Glutamate Receptor (MRG) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Metabotropic Glutamate Receptor (MRG) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 mGluR2
1.2.3 mGluR4
1.2.4 mGluR5
1.3 Market Analysis by Application
1.3.1 Overview: Global Metabotropic Glutamate Receptor (MRG) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Meningitis
1.3.3 Septicemia
1.3.4 Others
1.4 Overview of Global Metabotropic Glutamate Receptor (MRG) Market
1.4.1 Global Metabotropic Glutamate Receptor (MRG) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Addex Therapeutics (Switzerland)
2.1.1 Addex Therapeutics (Switzerland) Details
2.1.2 Addex Therapeutics (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Addex Therapeutics (Switzerland) SWOT Analysis
2.1.4 Addex Therapeutics (Switzerland) Product and Services
2.1.5 Addex Therapeutics (Switzerland) Metabotropic Glutamate Receptor (MRG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Prexton Therapeutics (Switzerland)
2.2.1 Prexton Therapeutics (Switzerland) Details
2.2.2 Prexton Therapeutics (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Prexton Therapeutics (Switzerland) SWOT Analysis
2.2.4 Prexton Therapeutics (Switzerland) Product and Services
2.2.5 Prexton Therapeutics (Switzerland) Metabotropic Glutamate Receptor (MRG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Domain Therapeutics (France)
2.3.1 Domain Therapeutics (France) Details
2.3.2 Domain Therapeutics (France) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Domain Therapeutics (France) SWOT Analysis
2.3.4 Domain Therapeutics (France) Product and Services
2.3.5 Domain Therapeutics (France) Metabotropic Glutamate Receptor (MRG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Medgenics (USA)
2.4.1 Medgenics (USA) Details
2.4.2 Medgenics (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Medgenics (USA) SWOT Analysis
2.4.4 Medgenics (USA) Product and Services
2.4.5 Medgenics (USA) Metabotropic Glutamate Receptor (MRG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Taisho Pharmaceutical Holding (Japan)
2.5.1 Taisho Pharmaceutical Holding (Japan) Details
2.5.2 Taisho Pharmaceutical Holding (Japan) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Taisho Pharmaceutical Holding (Japan) SWOT Analysis
2.5.4 Taisho Pharmaceutical Holding (Japan) Product and Services
2.5.5 Taisho Pharmaceutical Holding (Japan) Metabotropic Glutamate Receptor (MRG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Metabotropic Glutamate Receptor (MRG) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Metabotropic Glutamate Receptor (MRG) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Metabotropic Glutamate Receptor (MRG) Manufacturer Market Share in 2019
3.3.2 Top 6 Metabotropic Glutamate Receptor (MRG) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Market Share by Regions
4.1.1 Global Metabotropic Glutamate Receptor (MRG) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Metabotropic Glutamate Receptor (MRG) Revenue and Market Share by Regions (2015-2020)
4.2 North America Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
4.3 Europe Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
4.5 South America Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Market Share by Country
5.1.1 North America Metabotropic Glutamate Receptor (MRG) Sales and Market Share by Country (2015-2020)
5.1.2 North America Metabotropic Glutamate Receptor (MRG) Revenue and Market Share by Country (2015-2020)
5.2 United States Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
5.3 Canada Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
5.4 Mexico Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Market Share by Country
6.1.1 Europe Metabotropic Glutamate Receptor (MRG) Sales and Market Share by Country (2015-2020)
6.1.2 Europe Metabotropic Glutamate Receptor (MRG) Revenue and Market Share by Country (2015-2020)
6.2 Germany Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
6.3 UK Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
6.4 France Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
6.5 Russia Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
6.6 Italy Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Metabotropic Glutamate Receptor (MRG) Revenue and Market Share by Regions (2015-2020)
7.2 China Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
7.3 Japan Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
7.4 Korea Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
7.5 India Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
7.7 Australia Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Market Share by Country
8.1.1 South America Metabotropic Glutamate Receptor (MRG) Sales and Market Share by Country (2015-2020)
8.1.2 South America Metabotropic Glutamate Receptor (MRG) Revenue and Market Share by Country (2015-2020)
8.2 Brazil Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
8.3 Argentina Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Metabotropic Glutamate Receptor (MRG) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
9.3 Turkey Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
9.4 Egypt Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
9.5 South Africa Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Metabotropic Glutamate Receptor (MRG) Sales and Market Share by Type (2015-2020)
10.2 Global Metabotropic Glutamate Receptor (MRG) Revenue and Market Share by Type (2015-2020)
10.3 Global Metabotropic Glutamate Receptor (MRG) Price by Type (2015-2020)
11 Global Metabotropic Glutamate Receptor (MRG) Market Segment by Application
11.1 Global Metabotropic Glutamate Receptor (MRG) Sales Market Share by Application (2015-2020)
11.2 Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Application (2015-2020)
11.3 Global Metabotropic Glutamate Receptor (MRG) Price by Application (2015-2020)
12 Market Forecast
12.1 Global Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Growth Rate (2021-2025)
12.2 Metabotropic Glutamate Receptor (MRG) Market Forecast by Regions (2021-2025)
12.2.1 North America Metabotropic Glutamate Receptor (MRG) Market Forecast (2021-2025)
12.2.2 Europe Metabotropic Glutamate Receptor (MRG) Market Forecast (2021-2025)
12.2.3 Asia-Pacific Metabotropic Glutamate Receptor (MRG) Market Forecast (2021-2025)
12.2.4 South America Metabotropic Glutamate Receptor (MRG) Market Forecast (2021-2025)
12.2.5 Middle East & Africa Metabotropic Glutamate Receptor (MRG) Market Forecast (2021-2025)
12.3 Metabotropic Glutamate Receptor (MRG) Market Forecast by Type (2021-2025)
12.3.1 Global Metabotropic Glutamate Receptor (MRG) Sales Forecast by Type (2021-2025)
12.3.2 Global Metabotropic Glutamate Receptor (MRG) Market Share Forecast by Type (2021-2025)
12.4 Metabotropic Glutamate Receptor (MRG) Market Forecast by Application (2021-2025)
12.4.1 Global Metabotropic Glutamate Receptor (MRG) Sales Forecast by Application (2021-2025)
12.4.2 Global Metabotropic Glutamate Receptor (MRG) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Metabotropic Glutamate Receptor (MRG) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Metabotropic Glutamate Receptor (MRG) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Metabotropic Glutamate Receptor (MRG) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Addex Therapeutics (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 8. Addex Therapeutics (Switzerland) Metabotropic Glutamate Receptor (MRG) Major Business
Table 9. Addex Therapeutics (Switzerland) Metabotropic Glutamate Receptor (MRG) Total Revenue (USD Million) (2017-2018)
Table 10. Addex Therapeutics (Switzerland) SWOT Analysis
Table 11. Addex Therapeutics (Switzerland) Metabotropic Glutamate Receptor (MRG) Product and Services
Table 12. Addex Therapeutics (Switzerland) Metabotropic Glutamate Receptor (MRG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Prexton Therapeutics (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 14. Prexton Therapeutics (Switzerland) Metabotropic Glutamate Receptor (MRG) Major Business
Table 15. Prexton Therapeutics (Switzerland) Metabotropic Glutamate Receptor (MRG) Total Revenue (USD Million) (2017-2018)
Table 16. Prexton Therapeutics (Switzerland) SWOT Analysis
Table 17. Prexton Therapeutics (Switzerland) Metabotropic Glutamate Receptor (MRG) Product and Services
Table 18. Prexton Therapeutics (Switzerland) Metabotropic Glutamate Receptor (MRG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Domain Therapeutics (France) Basic Information, Manufacturing Base and Competitors
Table 20. Domain Therapeutics (France) Metabotropic Glutamate Receptor (MRG) Major Business
Table 21. Domain Therapeutics (France) Metabotropic Glutamate Receptor (MRG) Total Revenue (USD Million) (2017-2018)
Table 22. Domain Therapeutics (France) SWOT Analysis
Table 23. Domain Therapeutics (France) Metabotropic Glutamate Receptor (MRG) Product and Services
Table 24. Domain Therapeutics (France) Metabotropic Glutamate Receptor (MRG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Medgenics (USA) Basic Information, Manufacturing Base and Competitors
Table 26. Medgenics (USA) Metabotropic Glutamate Receptor (MRG) Major Business
Table 27. Medgenics (USA) Metabotropic Glutamate Receptor (MRG) Total Revenue (USD Million) (2017-2018)
Table 28. Medgenics (USA) SWOT Analysis
Table 29. Medgenics (USA) Metabotropic Glutamate Receptor (MRG) Product and Services
Table 30. Medgenics (USA) Metabotropic Glutamate Receptor (MRG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Taisho Pharmaceutical Holding (Japan) Basic Information, Manufacturing Base and Competitors
Table 32. Taisho Pharmaceutical Holding (Japan) Metabotropic Glutamate Receptor (MRG) Major Business
Table 33. Taisho Pharmaceutical Holding (Japan) Metabotropic Glutamate Receptor (MRG) Total Revenue (USD Million) (2017-2018)
Table 34. Taisho Pharmaceutical Holding (Japan) SWOT Analysis
Table 35. Taisho Pharmaceutical Holding (Japan) Metabotropic Glutamate Receptor (MRG) Product and Services
Table 36. Taisho Pharmaceutical Holding (Japan) Metabotropic Glutamate Receptor (MRG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Metabotropic Glutamate Receptor (MRG) Sales by Manufacturer (2018-2019) (K Units)
Table 38. Global Metabotropic Glutamate Receptor (MRG) Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Metabotropic Glutamate Receptor (MRG) Sales by Regions (2015-2020) (K Units)
Table 40. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share by Regions (2015-2020)
Table 41. Global Metabotropic Glutamate Receptor (MRG) Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Metabotropic Glutamate Receptor (MRG) Sales by Countries (2015-2020) (K Units)
Table 43. North America Metabotropic Glutamate Receptor (MRG) Sales Market Share by Countries (2015-2020)
Table 44. North America Metabotropic Glutamate Receptor (MRG) Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Countries (2015-2020)
Table 46. Europe Metabotropic Glutamate Receptor (MRG) Sales by Countries (2015-2020) (K Units)
Table 47. Europe Metabotropic Glutamate Receptor (MRG) Sales Market Share by Countries (2015-2020)
Table 48. Europe Metabotropic Glutamate Receptor (MRG) Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales by Regions (2015-2020) (K Units)
Table 50. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Metabotropic Glutamate Receptor (MRG) Sales by Countries (2015-2020) (K Units)
Table 53. South America Metabotropic Glutamate Receptor (MRG) Sales Market Share by Countries (2015-2020)
Table 54. South America Metabotropic Glutamate Receptor (MRG) Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Metabotropic Glutamate Receptor (MRG) Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Countries (2015-2020)
Table 60. Global Metabotropic Glutamate Receptor (MRG) Sales by Type (2015-2020) (K Units)
Table 61. Global Metabotropic Glutamate Receptor (MRG) Sales Share by Type (2015-2020)
Table 62. Global Metabotropic Glutamate Receptor (MRG) Revenue by Type (2015-2020) (USD Million)
Table 63. Global Metabotropic Glutamate Receptor (MRG) Revenue Share by Type (2015-2020)
Table 64. Global Metabotropic Glutamate Receptor (MRG) Sales by Application (2015-2020) (K Units)
Table 65. Global Metabotropic Glutamate Receptor (MRG) Sales Share by Application (2015-2020)
Table 66. Global Metabotropic Glutamate Receptor (MRG) Sales Forecast by Regions (2021-2025) (K Units)
Table 67. Global Metabotropic Glutamate Receptor (MRG) Market Share Forecast by Regions (2021-2025)
Table 68. Global Metabotropic Glutamate Receptor (MRG) Sales Forecast by Type (2021-2025) (K Units)
Table 69. Global Metabotropic Glutamate Receptor (MRG) Market Share Forecast by Type (2021-2025)
Table 70. Global Metabotropic Glutamate Receptor (MRG) Sales Forecast by Application (2021-2025)
Table 71. Global Metabotropic Glutamate Receptor (MRG) Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Metabotropic Glutamate Receptor (MRG) Picture
Figure 2. Global Sales Market Share of Metabotropic Glutamate Receptor (MRG) by Type in 2019
Figure 3. mGluR2 Picture
Figure 4. mGluR4 Picture
Figure 5. mGluR5 Picture
Figure 6. Metabotropic Glutamate Receptor (MRG) Sales Market Share by Application in 2018
Figure 7. Meningitis Picture
Figure 8. Septicemia Picture
Figure 9. Others Picture
Figure 10. Global Metabotropic Glutamate Receptor (MRG) Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Metabotropic Glutamate Receptor (MRG) Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share by Manufacturer in 2019
Figure 31. Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Metabotropic Glutamate Receptor (MRG) Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Metabotropic Glutamate Receptor (MRG) Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Metabotropic Glutamate Receptor (MRG) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Regions (2015-2020)
Figure 38. Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Regions in 2018
Figure 39. North America Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
Figure 40. Europe Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
Figure 42. South America Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020)
Figure 44. North America Metabotropic Glutamate Receptor (MRG) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Metabotropic Glutamate Receptor (MRG) Sales Market Share by Countries (2015-2020)
Figure 46. North America Metabotropic Glutamate Receptor (MRG) Sales Market Share by Countries in 2018
Figure 47. North America Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Countries in 2018
Figure 49. United States Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Metabotropic Glutamate Receptor (MRG) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Countries in 2019
Figure 55. Germany Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Regions 2019
Figure 63. China Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Metabotropic Glutamate Receptor (MRG) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Metabotropic Glutamate Receptor (MRG) Sales Market Share by Countries in 2019
Figure 70. South America Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Countries in 2019
Figure 71. Brazil Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Metabotropic Glutamate Receptor (MRG) Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Metabotropic Glutamate Receptor (MRG) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Metabotropic Glutamate Receptor (MRG) Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Metabotropic Glutamate Receptor (MRG) Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Metabotropic Glutamate Receptor (MRG) Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Metabotropic Glutamate Receptor (MRG) Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Metabotropic Glutamate Receptor (MRG) Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Addex Therapeutics (Switzerland)、Prexton Therapeutics (Switzerland)、Domain Therapeutics (France)、Medgenics (USA)、Taisho Pharmaceutical Holding (Japan)

★調査レポート[世界の代謝型グルタミン酸受容体(MRG)市場2020:製造業者別、地域別、種類・用途別] (コード:GIR20MY10068)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の代謝型グルタミン酸受容体(MRG)市場2020:製造業者別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆